Therapeutic Enzyme Drug Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product Type (Asparginase, Lipase, Protease, Nattokinase, Chitinase, Serratiopeptidase, Collagenase, Ligase, Others); Application (Leukemia, Stomach Disorders, Antitumor, Skin Ulcers, Gaucher disease, Fabry disease, Others); End-User (Drug manufacturers, Hospitals, Private clinics, Research laboratories)

Report Code: TIPRE00018840 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Enzymes are biochemical molecules released by living cells that act as biocatalysts and are extremely selective in their mode of action. Enzymes that can be used for medical purposes either in their isolated form or conjugation with some other therapies or drugs are called as therapeutic enzymes.

MARKET DYNAMICS

The therapeutic enzyme drugs market growth is driven by factors such as increasing number of cases of cancer and cardio vascular diseases globally. Also, the change in the lifestyle is responsible for increasing stress level which in turn is responsible for increasing the number of cases of pain disorders, consequently raising the demand for therapeutic enzymes. However, therapeutic enzyme therapies are expensive which may restrain market growth.

MARKET SCOPE

The "Therapeutic Enzyme Drugs Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of therapeutic enzyme drugs market with detailed market segmentation by product type, application, end-user and region. The therapeutic enzyme drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in therapeutic enzyme drugs market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The therapeutic enzyme drugs market is segmented on the basis of product type, application, end-user. Depending on product type, the market is classified into asparginase, lipase, protease, nattokinase, chitinase, serratiopeptidase, collagenase, ligase and others. By application, the market is classified into leukemia, stomach disorders, antitumor, skin ulcers, gaucher disease, fabry disease and others. According to end user, the market is segmented into drug manufacturers, hospitals, private clinics, research laboratories.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Therapeutic Enzyme Drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Therapeutic Enzyme Drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Therapeutic Enzyme Drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Therapeutic Enzyme Drugs market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the therapeutic enzyme drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from therapeutic enzyme drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for therapeutic enzyme drugs market in the global market. Below mentioned is the list of few companies engaged in the therapeutic enzyme drugs market.

The report also includes the profiles of key players in therapeutic enzyme drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Sanofi
- Pfizer
- BioMarin
- Shire
- Alexion
- AbbVie
- Johnson and Johnson
- Horizon Pharma
- Recordati Rare Diseases
- Allergan
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Therapeutic Enzyme Drugs Market - By Product Type
1.3.2 Therapeutic Enzyme Drugs Market - By Application
1.3.3 Therapeutic Enzyme Drugs Market - By End-User
1.3.4 Therapeutic Enzyme Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. THERAPEUTIC ENZYME DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. THERAPEUTIC ENZYME DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. THERAPEUTIC ENZYME DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. THERAPEUTIC ENZYME DRUGS - GLOBAL MARKET OVERVIEW
6.2. THERAPEUTIC ENZYME DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. THERAPEUTIC ENZYME DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. ASPARGINASE
7.3.1. Overview
7.3.2. Asparginase Market Forecast and Analysis
7.4. LIPASE
7.4.1. Overview
7.4.2. Lipase Market Forecast and Analysis
7.5. PROTEASE
7.5.1. Overview
7.5.2. Protease Market Forecast and Analysis
7.6. NATTOKINASE
7.6.1. Overview
7.6.2. Nattokinase Market Forecast and Analysis
7.7. CHITINASE
7.7.1. Overview
7.7.2. Chitinase Market Forecast and Analysis
7.8. SERRATIOPEPTIDASE
7.8.1. Overview
7.8.2. Serratiopeptidase Market Forecast and Analysis
7.9. COLLAGENASE
7.9.1. Overview
7.9.2. Collagenase Market Forecast and Analysis
7.10. LIGASE
7.10.1. Overview
7.10.2. Ligase Market Forecast and Analysis
7.11. OTHERS
7.11.1. Overview
7.11.2. Others Market Forecast and Analysis
8. THERAPEUTIC ENZYME DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. LEUKEMIA
8.3.1. Overview
8.3.2. Leukemia Market Forecast and Analysis
8.4. STOMACH DISORDERS
8.4.1. Overview
8.4.2. Stomach Disorders Market Forecast and Analysis
8.5. ANTITUMOR
8.5.1. Overview
8.5.2. Antitumor Market Forecast and Analysis
8.6. SKIN ULCERS
8.6.1. Overview
8.6.2. Skin Ulcers Market Forecast and Analysis
8.7. GAUCHER DISEASE
8.7.1. Overview
8.7.2. Gaucher disease Market Forecast and Analysis
8.8. FABRY DISEASE
8.8.1. Overview
8.8.2. Fabry disease Market Forecast and Analysis
8.9. OTHERS
8.9.1. Overview
8.9.2. Others Market Forecast and Analysis
9. THERAPEUTIC ENZYME DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - END-USER
9.1. OVERVIEW
9.2. END-USER MARKET FORECASTS AND ANALYSIS
9.3. DRUG MANUFACTURERS
9.3.1. Overview
9.3.2. Drug manufacturers Market Forecast and Analysis
9.4. HOSPITALS
9.4.1. Overview
9.4.2. Hospitals Market Forecast and Analysis
9.5. PRIVATE CLINICS
9.5.1. Overview
9.5.2. Private clinics Market Forecast and Analysis
9.6. RESEARCH LABORATORIES
9.6.1. Overview
9.6.2. Research laboratories Market Forecast and Analysis
10. THERAPEUTIC ENZYME DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Therapeutic Enzyme Drugs Market Overview
10.1.2 North America Therapeutic Enzyme Drugs Market Forecasts and Analysis
10.1.3 North America Therapeutic Enzyme Drugs Market Forecasts and Analysis - By Product Type
10.1.4 North America Therapeutic Enzyme Drugs Market Forecasts and Analysis - By Application
10.1.5 North America Therapeutic Enzyme Drugs Market Forecasts and Analysis - By End-User
10.1.6 North America Therapeutic Enzyme Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Therapeutic Enzyme Drugs Market
10.1.6.1.1 United States Therapeutic Enzyme Drugs Market by Product Type
10.1.6.1.2 United States Therapeutic Enzyme Drugs Market by Application
10.1.6.1.3 United States Therapeutic Enzyme Drugs Market by End-User
10.1.6.2 Canada Therapeutic Enzyme Drugs Market
10.1.6.2.1 Canada Therapeutic Enzyme Drugs Market by Product Type
10.1.6.2.2 Canada Therapeutic Enzyme Drugs Market by Application
10.1.6.2.3 Canada Therapeutic Enzyme Drugs Market by End-User
10.1.6.3 Mexico Therapeutic Enzyme Drugs Market
10.1.6.3.1 Mexico Therapeutic Enzyme Drugs Market by Product Type
10.1.6.3.2 Mexico Therapeutic Enzyme Drugs Market by Application
10.1.6.3.3 Mexico Therapeutic Enzyme Drugs Market by End-User
10.2. EUROPE
10.2.1 Europe Therapeutic Enzyme Drugs Market Overview
10.2.2 Europe Therapeutic Enzyme Drugs Market Forecasts and Analysis
10.2.3 Europe Therapeutic Enzyme Drugs Market Forecasts and Analysis - By Product Type
10.2.4 Europe Therapeutic Enzyme Drugs Market Forecasts and Analysis - By Application
10.2.5 Europe Therapeutic Enzyme Drugs Market Forecasts and Analysis - By End-User
10.2.6 Europe Therapeutic Enzyme Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Therapeutic Enzyme Drugs Market
10.2.6.1.1 Germany Therapeutic Enzyme Drugs Market by Product Type
10.2.6.1.2 Germany Therapeutic Enzyme Drugs Market by Application
10.2.6.1.3 Germany Therapeutic Enzyme Drugs Market by End-User
10.2.6.2 France Therapeutic Enzyme Drugs Market
10.2.6.2.1 France Therapeutic Enzyme Drugs Market by Product Type
10.2.6.2.2 France Therapeutic Enzyme Drugs Market by Application
10.2.6.2.3 France Therapeutic Enzyme Drugs Market by End-User
10.2.6.3 Italy Therapeutic Enzyme Drugs Market
10.2.6.3.1 Italy Therapeutic Enzyme Drugs Market by Product Type
10.2.6.3.2 Italy Therapeutic Enzyme Drugs Market by Application
10.2.6.3.3 Italy Therapeutic Enzyme Drugs Market by End-User
10.2.6.4 Spain Therapeutic Enzyme Drugs Market
10.2.6.4.1 Spain Therapeutic Enzyme Drugs Market by Product Type
10.2.6.4.2 Spain Therapeutic Enzyme Drugs Market by Application
10.2.6.4.3 Spain Therapeutic Enzyme Drugs Market by End-User
10.2.6.5 United Kingdom Therapeutic Enzyme Drugs Market
10.2.6.5.1 United Kingdom Therapeutic Enzyme Drugs Market by Product Type
10.2.6.5.2 United Kingdom Therapeutic Enzyme Drugs Market by Application
10.2.6.5.3 United Kingdom Therapeutic Enzyme Drugs Market by End-User
10.2.6.6 Rest of Europe Therapeutic Enzyme Drugs Market
10.2.6.6.1 Rest of Europe Therapeutic Enzyme Drugs Market by Product Type
10.2.6.6.2 Rest of Europe Therapeutic Enzyme Drugs Market by Application
10.2.6.6.3 Rest of Europe Therapeutic Enzyme Drugs Market by End-User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Therapeutic Enzyme Drugs Market Overview
10.3.2 Asia-Pacific Therapeutic Enzyme Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Therapeutic Enzyme Drugs Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Therapeutic Enzyme Drugs Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Therapeutic Enzyme Drugs Market Forecasts and Analysis - By End-User
10.3.6 Asia-Pacific Therapeutic Enzyme Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Therapeutic Enzyme Drugs Market
10.3.6.1.1 Australia Therapeutic Enzyme Drugs Market by Product Type
10.3.6.1.2 Australia Therapeutic Enzyme Drugs Market by Application
10.3.6.1.3 Australia Therapeutic Enzyme Drugs Market by End-User
10.3.6.2 China Therapeutic Enzyme Drugs Market
10.3.6.2.1 China Therapeutic Enzyme Drugs Market by Product Type
10.3.6.2.2 China Therapeutic Enzyme Drugs Market by Application
10.3.6.2.3 China Therapeutic Enzyme Drugs Market by End-User
10.3.6.3 India Therapeutic Enzyme Drugs Market
10.3.6.3.1 India Therapeutic Enzyme Drugs Market by Product Type
10.3.6.3.2 India Therapeutic Enzyme Drugs Market by Application
10.3.6.3.3 India Therapeutic Enzyme Drugs Market by End-User
10.3.6.4 Japan Therapeutic Enzyme Drugs Market
10.3.6.4.1 Japan Therapeutic Enzyme Drugs Market by Product Type
10.3.6.4.2 Japan Therapeutic Enzyme Drugs Market by Application
10.3.6.4.3 Japan Therapeutic Enzyme Drugs Market by End-User
10.3.6.5 South Korea Therapeutic Enzyme Drugs Market
10.3.6.5.1 South Korea Therapeutic Enzyme Drugs Market by Product Type
10.3.6.5.2 South Korea Therapeutic Enzyme Drugs Market by Application
10.3.6.5.3 South Korea Therapeutic Enzyme Drugs Market by End-User
10.3.6.6 Rest of Asia-Pacific Therapeutic Enzyme Drugs Market
10.3.6.6.1 Rest of Asia-Pacific Therapeutic Enzyme Drugs Market by Product Type
10.3.6.6.2 Rest of Asia-Pacific Therapeutic Enzyme Drugs Market by Application
10.3.6.6.3 Rest of Asia-Pacific Therapeutic Enzyme Drugs Market by End-User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Therapeutic Enzyme Drugs Market Overview
10.4.2 Middle East and Africa Therapeutic Enzyme Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Therapeutic Enzyme Drugs Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Therapeutic Enzyme Drugs Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Therapeutic Enzyme Drugs Market Forecasts and Analysis - By End-User
10.4.6 Middle East and Africa Therapeutic Enzyme Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Therapeutic Enzyme Drugs Market
10.4.6.1.1 South Africa Therapeutic Enzyme Drugs Market by Product Type
10.4.6.1.2 South Africa Therapeutic Enzyme Drugs Market by Application
10.4.6.1.3 South Africa Therapeutic Enzyme Drugs Market by End-User
10.4.6.2 Saudi Arabia Therapeutic Enzyme Drugs Market
10.4.6.2.1 Saudi Arabia Therapeutic Enzyme Drugs Market by Product Type
10.4.6.2.2 Saudi Arabia Therapeutic Enzyme Drugs Market by Application
10.4.6.2.3 Saudi Arabia Therapeutic Enzyme Drugs Market by End-User
10.4.6.3 U.A.E Therapeutic Enzyme Drugs Market
10.4.6.3.1 U.A.E Therapeutic Enzyme Drugs Market by Product Type
10.4.6.3.2 U.A.E Therapeutic Enzyme Drugs Market by Application
10.4.6.3.3 U.A.E Therapeutic Enzyme Drugs Market by End-User
10.4.6.4 Rest of Middle East and Africa Therapeutic Enzyme Drugs Market
10.4.6.4.1 Rest of Middle East and Africa Therapeutic Enzyme Drugs Market by Product Type
10.4.6.4.2 Rest of Middle East and Africa Therapeutic Enzyme Drugs Market by Application
10.4.6.4.3 Rest of Middle East and Africa Therapeutic Enzyme Drugs Market by End-User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Therapeutic Enzyme Drugs Market Overview
10.5.2 South and Central America Therapeutic Enzyme Drugs Market Forecasts and Analysis
10.5.3 South and Central America Therapeutic Enzyme Drugs Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Therapeutic Enzyme Drugs Market Forecasts and Analysis - By Application
10.5.5 South and Central America Therapeutic Enzyme Drugs Market Forecasts and Analysis - By End-User
10.5.6 South and Central America Therapeutic Enzyme Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Therapeutic Enzyme Drugs Market
10.5.6.1.1 Brazil Therapeutic Enzyme Drugs Market by Product Type
10.5.6.1.2 Brazil Therapeutic Enzyme Drugs Market by Application
10.5.6.1.3 Brazil Therapeutic Enzyme Drugs Market by End-User
10.5.6.2 Argentina Therapeutic Enzyme Drugs Market
10.5.6.2.1 Argentina Therapeutic Enzyme Drugs Market by Product Type
10.5.6.2.2 Argentina Therapeutic Enzyme Drugs Market by Application
10.5.6.2.3 Argentina Therapeutic Enzyme Drugs Market by End-User
10.5.6.3 Rest of South and Central America Therapeutic Enzyme Drugs Market
10.5.6.3.1 Rest of South and Central America Therapeutic Enzyme Drugs Market by Product Type
10.5.6.3.2 Rest of South and Central America Therapeutic Enzyme Drugs Market by Application
10.5.6.3.3 Rest of South and Central America Therapeutic Enzyme Drugs Market by End-User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL THERAPEUTIC ENZYME DRUGS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. THERAPEUTIC ENZYME DRUGS MARKET, KEY COMPANY PROFILES
13.1. SANOFI
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. PFIZER
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BIOMARIN
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. SHIRE
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. ALEXION
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ABBVIE
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. JOHNSON AND JOHNSON
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. HORIZON PHARMA
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. RECORDATI RARE DISEASES
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ALLERGAN
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Sanofi
2. Pfizer
3. BioMarin
4. Shire
5. Alexion
6. AbbVie
7. Johnson and Johnson
8. Horizon Pharma
9. Recordati Rare Diseases
10. Allergan

TIPRE00018840
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking